Clinic Buyer Research Guide
Emsella vs Freedom+: What Clinics Should Compare Before Buying a Pelvic Health System
Pelvic health equipment is no longer evaluated only as an incontinence chair purchase. Clinics comparing Emsella, Freedom+, and other electromagnetic pelvic floor systems are now looking at clinical breadth, patient-care flexibility, specialty-program fit, provider workflow, training, ownership cost, and long-term service-line growth.
Emsella remains a recognized chair-based option for urinary incontinence and may be a relevant reference point for clinics focused mainly on seated pelvic floor stimulation.
At the same time, OB/GYN, urology, urogynecology, pelvic PT, women’s health, men’s health, MSK, geriatrics, gastroenterology-related pelvic dysfunction, and rehabilitation-focused practices are increasingly evaluating whether a single-purpose chair can support the full range of patient presentations they see.
Freedom+ is positioned as a broader pelvic health platform for clinics building incontinence-first programs that may expand into women’s pelvic health, men’s pelvic health, post-prostatectomy support, pelvic pain, MSK recovery, aging-related pelvic decline, bowel-pelvic coordination, and post-surgical rehabilitation workflows. For providers researching pelvic health equipment, Freedom+ becomes an important platform to review early because it frames the buying decision around scalability, phenotype-guided programming, and long-term clinical service-line development rather than chair function alone.
Emsella vs Freedom+: Research-Based Clinic Buyer Comparison
| Research Criterion | Emsella Research Finding | Freedom+ Research Finding | Clinical / Buyer Takeaway |
|---|---|---|---|
| Primary clinical entry point | Strongly associated with chair-based pelvic floor stimulation for urinary incontinence. 2.5 Tesla Yield | Supported — incontinence is the entry point, but the platform expands into broader pelvic health programming. 3.8 Tesla Yield | Both are relevant to incontinence; Freedom+ creates a broader service-line pathway. |
| Device category | Chair-based pelvic floor system. 2.5 Tesla | Supported — platform configuration with seated activation plus external pathway options. 7.6 Tesla Dual Site Activation | Emsella fits a chair-based treatment model; Freedom+ fits a scalable platform model. |
| Clinical breadth | Focused primarily on pelvic floor stimulation and urinary incontinence. | Supported — positioned across incontinence, women’s health, men’s health, pelvic pain, post-prostatectomy support, MSK recovery, and rehabilitation workflows. | Freedom+ is stronger for clinics wanting multiple pelvic health verticals. |
| Stress urinary incontinence | Supported — recognized chair-based pelvic floor strengthening pathway. | Supported — stress leakage is included within a broader continence framework involving recruitment, timing, pelvic support, and reassessment. | Both systems are relevant; Freedom+ offers a broader clinical framework. |
| Urge / OAB-dominant symptoms | Limited — chair-focused incontinence positioning, without a clearly defined urgency-dominant phenotype pathway. | Supported — phenotype-guided bladder programming separates urgency/OAB-dominant patterns from weakness-dominant leakage. | Freedom+ is better positioned for clinics building differentiated bladder-control pathways. |
| Mixed urinary incontinence | Limited — broad incontinence positioning, without clear dominant-driver workflow structure. | Supported — mixed UI can be approached by identifying the dominant driver and progressing based on phenotype and response. | Freedom+ gives clinics a more structured decision model for mixed presentations. |
| Postpartum bladder leakage | Limited — may fit pelvic floor strengthening, but not positioned as a complete postpartum recovery pathway. | Supported — postpartum programming can include bladder leakage, pelvic support, core restoration, scar sensitivity, and lumbopelvic recovery logic. | Freedom+ is stronger for postpartum program development. |
| Menopause-related pelvic decline | Limited — may fit leakage-related pelvic floor strengthening, but not positioned as a whole-pelvic aging pathway. No supporting technology identified. | Supported — menopause and pelvic aging can be addressed through whole-pelvic / whole-core programming, including bladder, support, tissue tolerance, sexual comfort, and functional decline. | Freedom+ supports a broader women’s health and pelvic-aging narrative. |
| Women’s health specialization | Chair-focused; not positioned as a broad women’s health platform. No supporting technology identified. | Supported — positioned for incontinence, postpartum recovery, menopause-related decline, pelvic support, sexual comfort, and aging-related pelvic health. | Freedom+ is stronger for OB/GYN and women’s health clinics building specialty programs. |
| Men’s pelvic health | Supported for urinary incontinence in men and women, but not positioned as a broad men’s pelvic health platform. No additional supporting technology identified. | Supported — includes men’s pelvic health, post-prostatectomy leakage, LUTS, CPPS/prostatitis-like symptoms, dysfunctional voiding, and pelvic aging decline. | Freedom+ has stronger positioning for urology and men’s health clinics. |
| Post-prostatectomy support | Limited — urinary incontinence is addressed, but not positioned as a detailed peri/post-prostatectomy recovery continuum. No supporting technology identified. | Supported — men’s pelvic urology pathways include peri/post-prostatectomy recovery and leakage support. | Freedom+ is stronger for clinics building post-prostatectomy service lines. |
| ED / male pelvic performance pathway | No — not positioned for this pathway, with no supporting technology identified. | Supported — selected male pelvic rehabilitation workflows may address under-recruitment, timing, endurance, guarding, post-surgical inhibition, and sacral-pudendal coordination deficits. | Freedom+ offers a broader men’s pelvic health and neurofunctional rehabilitation story. |
| Pelvic pain / guarding / pain-sensitive phenotypes | No — not positioned for this pathway, with no supporting technology identified. | Supported — phenotype-guided workflow with external pathway options for guarded, pain-sensitive, or reduced-tolerance pelvic presentations. | Clinics treating pelvic pain or guarding should compare whether they need a broader platform beyond chair-based incontinence. |
| Tissue-readiness / comfort support | No — not positioned for this pathway, with no supporting technology identified. | Supported — FMS + RWT platform positioning allows neuromuscular activation plus external tissue-readiness and comfort-support workflows. | Important for clinics managing sensitivity, tolerance, staged pelvic rehab, or pain-aware programming. |
| External sacral / lumbosacral support | No — no dedicated external sacral or lumbosacral pathway identified. | Supported — Vitality Seat can be combined with Synerji external sacral/lumbosacral support in selected workflows. | Freedom+ offers a broader pathway strategy beyond seated pelvic floor activation. |
| MSK / recovery expansion | No — not positioned for this pathway, with no supporting technology identified. | Supported — external FMS + RWT platform positioning extends into pain-support, MSK, recovery, and functional rehabilitation workflows. | Freedom+ is stronger for clinics seeking pelvic health plus MSK/recovery expansion. |
| Gastroenterology / bowel-pelvic coordination | No — not positioned for this pathway, with no supporting technology identified. | Supported — positioned around bowel/bladder coordination and whole-pelvic functional pathways. | Freedom+ is more relevant for clinics treating broader pelvic floor coordination issues. |
Research findings are based on reviewed public-facing positioning, clinic-buyer comparison criteria, and platform information available for each system. Clinics should verify current indications, configurations, pricing, training, service terms, and clinical-use claims directly with each manufacturer before purchase.
Freedom+ and Emsella Device Comparison
Freedom+ Platform
Emsella Chair
Emsella vs Freedom+: Non-Indication
System Platform & Ownership Comparison
| Research Criterion | Emsella Research Finding | Freedom+ Research Finding | Clinic / Buyer Takeaway |
|---|---|---|---|
| System category | Chair-based pelvic floor system. | Supported - platform-based pelvic health system with seated and external pathway options. | This is the core difference: chair purchase vs scalable platform investment. |
| Primary equipment format | Single seated chair configuration. | Supported - modular platform configuration may include Host Tower, Vitality Seat, Synerji Pro, Synerji Acute, and external applicator options. | Freedom+ gives clinics more configuration flexibility. |
| Technology positioning | HIFEM chair-based electromagnetic stimulation. | Supported - FMS platform positioning with optional RWT support pathways, depending on configuration. | Emsella is chair-focused; Freedom+ is positioned as a broader technology platform. |
| Magnetic output | Reported/quoted as 2.5 Tesla in reviewed comparison materials; verify against current manufacturer documentation. | Reported/quoted as 3.8 Tesla per channel / dual-site activation in reviewed comparison materials; verify by configuration and engineering documentation. | Avoid relying on headline Tesla claims alone; compare measured output, configuration, duty cycle, and workflow. |
| Contraction-count positioning | Commonly positioned around seated pelvic floor contraction sessions. | Supported - positioned around seated pelvic floor activation plus broader programmed workflows. | Contraction count alone is not enough; workflow depth and platform flexibility matter. |
| Power / engineering capacity | Chair-based system; confirm current wattage and electrical specifications with vendor. | Supported - reviewed comparison materials position Freedom+ as a heavier-duty platform configuration; confirm exact wattage and model specifications. | Engineering comparison should be validated by specification sheets, not marketing claims alone. |
| Country / engineering origin | Manufacturer origin and production details should be verified with current vendor documentation. | Positioned as German-engineered / Germany-based technology; verify country-of-origin language in final sales documentation. | Engineering origin can support buyer confidence, but it should be documented accurately. |
| Patient capability | Single-patient chair workflow. | Supported - dual-patient capability may be available depending on configuration. | Freedom+ may offer stronger throughput potential for clinics planning higher-volume programs. |
| Regulatory / clearance status | Reported as cleared/marketed for pelvic floor stimulation use; verify exact device model, indication language, and current documentation. | Reported as cleared/marketed for pelvic health platform use; verify exact device model, indication language, and current documentation. | Regulatory status should be verified directly; do not assume identical indications or claims. |
| Licensing / recurring fees | Confirm current licensing, software, service, and recurring fee structure with vendor. | Positioned with no licensing fees in reviewed sales positioning; confirm in final quote and purchase documents. | Recurring fees can materially affect ROI and should be verified before purchase. |
| Phenotype-guided programming | No - not positioned as a phenotype-guided platform. | Supported - workflows are positioned around matching clinical pathways to bladder, pelvic floor, pain, postpartum, menopause, men's health, and recovery presentations. | This is one of Freedom+'s strongest differentiation points. |
| Integrated FMS + RWT platform | No - chair-based electromagnetic stimulation only in reviewed positioning. | Supported - combines FMS + RWT for neuromuscular recruitment, external support, tissue-readiness, and comfort-oriented workflows. | Freedom+ has the broader multimodal platform story. |
| External applicator options | No - not positioned with external applicator pathways. | Supported - Synerji external applicators expand the system beyond seated pelvic floor stimulation. | Freedom+ gives clinics more treatment-pathway flexibility. |
| Tissue-readiness / comfort workflow | No - not positioned for this pathway, with no supporting technology identified. | Supported - RWT-enabled external pathways can support comfort, tissue-readiness, and staged workflow logic. | Important for clinics that want broader workflow flexibility beyond contraction-only treatment. |
| External sacral / lumbosacral pathway | No - no dedicated external sacral or lumbosacral pathway identified. | Supported - Vitality Seat can be combined with Synerji external sacral/lumbosacral support in selected workflows. | Freedom+ offers a broader pathway strategy beyond chair-only stimulation. |
| Modular configuration | Limited - primarily chair-based configuration. | Supported - modular platform options allow clinics to start focused and expand over time. | Freedom+ is stronger for clinics planning long-term service-line growth. |
| Software / preset workflow | Simple chair protocol structure; confirm software depth with vendor. | Supported - simplified presets plus advanced workflow logic help clinics standardize programs while allowing clinical flexibility. | Freedom+ provides a stronger platform-management story. |
| Workflow flexibility | Simple chair-based workflow; operator-independent positioning may be attractive for basic incontinence programs. | Supported - preset and advanced workflow logic allows clinics to build programs by clinical intent and patient phenotype. | Emsella is simpler; Freedom+ is broader and more programmable. |
| Training and implementation support | Confirm with vendor; support may vary by distributor, package, and region. | Supported - positioned with provider training, clinical workflow support, patient education, launch support, and practice-growth tools. | Freedom+ is stronger for clinics needing structured onboarding and launch support. |
| Practice-growth model | Recognizable chair-based incontinence offering; may support a narrower single treatment line. | Supported - platform model supports incontinence-first growth with expansion into additional specialty programs. | Freedom+ has the stronger long-term business-growth narrative. |
| Service and warranty terms | Confirm warranty, service response, parts, distributor support, and maintenance terms. | Confirm warranty, training, service response, parts, and support package by configuration. | Service terms matter as much as device price. |
| Market recognition | Strong recognition as a pelvic floor chair brand. | Emerging as a broader pelvic health platform option for clinics seeking scalability. | Emsella has brand recognition; Freedom+ has the stronger platform-expansion story. |
| Best-fit buyer profile | Clinics wanting a familiar chair-based pelvic floor system. | Clinics wanting a scalable platform across multiple specialty verticals and workflows. | The best choice depends on whether the clinic wants a chair or a platform. |
| Core buyer question | Should we add an incontinence chair? | Should our clinic invest in a broader pelvic health platform? | Freedom+ becomes the stronger choice when the clinic is planning beyond chair-only treatment. |
| Average invoice / purchase-price range | Reported average invoice range: $170,000-$190,000. | Reported average invoice range: $95,000-$145,000, depending on configuration. | Pricing materially affects ROI. Clinics should compare total purchase cost, included technology, training, warranty, service, configuration, financing, and long-term expansion value - not device price alone. |
Emsella vs Freedom+: Technical Specification
and Platform Architecture Comparison
| Technical Spec / System Factor | Emsella Research Finding | Freedom+ Research Finding | Clinic / Buyer Takeaway |
|---|---|---|---|
| System generation / release | Reported as Generation 1 chair-based pelvic floor technology. | Reported as Generation 5.1 pelvic health platform. | Freedom+ presents as a newer-generation platform, while Emsella remains a first-generation chair-style system. |
| System architecture | Chair-based electromagnetic pelvic floor system. | Modular pelvic health platform with seated and external pathway options. | Core distinction: Emsella is a chair-based system; Freedom+ is positioned as a scalable platform architecture. |
| Core components | Integrated chair system with internal stimulation coil and power system. | Freedom Body Host / tower, Vitality Seat, Synerji external applicator system, and optional modular expansion depending on package. | Emsella is built into one chair; Freedom+ separates the power platform from selectable applicators. |
| Tower / host unit | No separate modular tower pathway identified; the chair is the treatment unit. | Supported — host/tower platform designed to power multiple components and configurations. | Freedom+ is stronger for clinics planning staged expansion. |
| Chair / seat pathway | Chair-style applicator; patient remains seated and fully clothed. | Vitality Seat supports seated pelvic floor FMS; Freedom Chair is a separate dedicated chair-style system. | Both offer seated treatment; Freedom+ adds platform expansion beyond the seat. |
| Technology type | HIFEM electromagnetic stimulation. | FMS platform positioning, with RWT support pathways available through Synerji configuration. | Emsella is magnetic chair stimulation; Freedom+ adds multimodal platform positioning. |
| Magnetic field / Tesla | Reported positioning commonly references up to 2.5 Tesla; verify against current manufacturer spec sheet. | Reported Freedom values include 3.8 Tesla per Vitality Seat and 3.1 Tesla for Freedom Chair; verify by official engineering documentation. | Tesla claims should be compared by coil geometry, measurement method, duty cycle, applicator type, and final manufacturer documentation. |
| Rated power / wattage |
Reported as 1500 W. | Reported as 2500 W. | Freedom+ presents a higher reported power platform; wattage should still be verified against official technical documentation. |
| Frequency / thermal-load behavior | Reported as static 30 Hz muscular thermal-load balance. | Reported as dynamic thermal-load programming that includes 30 Hz within broader workflow logic. | Freedom+ should be positioned as broader and more adaptive, not simply higher frequency. |
| Session duration | Commonly positioned around chair-based sessions; verify current protocol timing by vendor. | Reported 10–30 minute sessions, depending on indication and workflow. | Freedom+ gives clinics more timing flexibility across different clinical pathways. |
| Number of indications / preset pathways | Reported as 4 indications. | Reported as 109 indications / preset pathways. | Major platform distinction: limited chair indications versus broad clinical-program scalability. |
| Software highlights | Simple chair-based workflow with limited indication structure. | Generation 5.1 software with broader preset logic, workflow depth, and indication-based programming. | Freedom+ has the stronger software and workflow-scalability story. |
| Phenotype-guided programming | No — not positioned as a phenotype-guided platform. | Supported — workflows can be organized around bladder, pelvic floor, pain, postpartum, menopause, men’s health, MSK, and recovery presentations. | Important for specialty clinics wanting structured pathways rather than one chair protocol. |
| External applicator options | No — not positioned with external applicator pathways. | Supported — Synerji external applicators expand the platform beyond seated pelvic floor stimulation. | Freedom+ gives clinics more treatment-pathway flexibility. |
| External sacral / lumbosacral pathway | No — no dedicated external sacral or lumbosacral pathway identified. | Supported — Vitality Seat can be combined with Synerji external sacral/lumbosacral support in selected workflows. | Freedom+ offers a broader pathway strategy beyond chair-only stimulation. |
| Integrated FMS + RWT platform | No — chair-based electromagnetic stimulation only in reviewed positioning. | Supported — combines FMS + RWT for neuromuscular activation, external support, tissue-readiness, comfort, and workflow expansion. | Freedom+ has the broader multimodal platform story. |
| MSK / recovery technology pathway | No — not positioned for this pathway, with no supporting technology identified. | Supported — external FMS + RWT platform positioning extends into pain-support, MSK, recovery, and functional rehabilitation workflows. | Freedom+ is stronger for clinics seeking pelvic health plus MSK/recovery expansion. |
| Programmed contraction positioning | Commonly positioned around high-volume seated pelvic floor contraction sessions. | Positioned around seated pelvic floor activation plus broader programmed workflows and external pathway options. | Contraction count is useful, but workflow depth and platform flexibility matter more for a serious clinic comparison. |
| Consumables / timer-count model | Historically associated with a recharge / timer-card refill model; verify current vendor terms. | Reported as no consumables and no timer-count refill model. | Freedom+ may offer stronger long-term ownership value if no per-use timer or refill model applies. |
| Licensing / recurring-use fees | Confirm current licensing, refill, software, service, and recurring-fee structure with vendor. | Reported as no licensing or timer-count refill model; confirm in final quote. | Recurring cost s can materially affect ROI and should be verified before purchase. |
| Warranty | Reported 1-year warranty. | Reported 3-year warranty. | Freedom+ presents stronger warranty coverage for capital-equipment buyers. |
| Training and implementation | Confirm training, onboarding, and launch support with vendor or distributor. | Supported — positioned with provider training, workflow support, patient education materials, launch support, and practice-growth tools. | Freedom+ is stronger for clinics needing structured implementation support. |
| Service / support model | Confirm service response, parts, distributor support, maintenance terms, and software support. | Confirm service response, parts, training, support package, and applicator coverage by configuration. | Service terms should be compared as carefully as device price. |
| Installation / electrical requirements | Confirm room, electrical, clearance, delivery, and installation requirements with vendor. | Confirm tower, seat, applicator, room layout, electrical, delivery, and configuration requirements by setup. | Installation affects project cost, treatment-room planning, and implementation timeline. |
| Average invoice / purchase-price range | Reported average invoice range: $170,000–$190,000. | Reported average invoice range: $95,000–$145,000, depending on configuration. | Price should be compared against included components, warranty, training, service, software, workflow depth, and long-term expansion value. |
| Best technical fit | Clinics wanting a familiar chair-based pelvic floor system. | Clinics wanting a scalable technology platform across multiple pathways, components, and specialty programs. | The best choice depends on whether the clinic wants a chair or a broader platform architecture. |
Technical findings are based on reviewed public-facing materials, buyer-comparison criteria, and manufacturer-reported or sales-reported specifications. Clinics should verify current generation, wattage, Tesla output, software features, indication count, warranty, pricing, timer/refill requirements, service terms, installation requirements, and configuration details directly with each manufacturer before purchase.
What Is an Incontinence Chair?
Why Should Clinics Compare Pelvic Therapy Systems?
Pelvic Therapy Chair Technology Comparison Overview
Pelvic floor magnetic therapy systems use electromagnetic energy to activate pelvic floor muscles and support neuromuscular recruitment. HIFEM-based chair systems, including Emsella, are recognized for chair-based pelvic floor stimulation and incontinence-focused treatment. FMS-based platforms, including Freedom+, are positioned around programmable stimulation, workflow flexibility, and broader clinical pathway development.
For clinics, this distinction is important. A standardized chair may help introduce pelvic floor therapy into a practice, but a scalable platform can support more specialized clinical programs, multiple patient phenotypes, training depth, service-line expansion, and long-term business growth. That is why many providers now compare pelvic therapy systems not only by power or contraction count, but by adaptability, technology architecture, clinical breadth, software workflow, support model, and total ownership value.
Visit Manufacturer Websites
Want to explore each platform directly?
📥 Download the 2025 Comparison Guide
Want to compare both devices offline? Download our printable PDF covering specs, technology, pricing, and ROI data for Freedom+ and Emsella.
Frequently Asked Questions
What is Emsella?
Emsella is an FDA-cleared chair that uses HIFEM technology to stimulate pelvic floor muscles, primarily for treating urinary incontinence. For clinics looking to explore newer-generation systems, Freedom+ is one emerging option.
What is an Emsella chair used for?
The Emsella chair is used to deliver non-invasive pelvic floor stimulation to treat stress, urge, and mixed urinary incontinence. While it remains widely used, newer chairs like Freedom+ offer different stimulation algorithms and broader applications.
Where can I purchase an Emsella chair?
Emsella chairs are sold through authorized BTL distributors. Pricing, service agreements, and licensing requirements vary by provider.
What is the cost of an Emsella chair in 2025?
Most Emsella chair quotes range between $130,000 and $179,000 USD, depending on region, package, and service terms. Some clinics compare this to newer platforms like Freedom+, which start at a lower base price.
Is Emsella effective for urinary incontinence?
Yes. Emsella is FDA-cleared and clinically proven to treat urinary incontinence through electromagnetic pelvic floor stimulation.
How many sessions are needed with Emsella?
Typical Emsella treatment protocols involve 6 to 8 sessions, scheduled every 2 to 3 days.
Does Emsella require licensing or maintenance fees?
Yes. Most Emsella clinics report annual licensing and/or marketing fees that add to the long-term cost of ownership.
Is there an alternative to Emsella?
Freedom+ is the next-generation alternative to Emsella. It offers dynamic stimulation, expanded clinical applications, and no licensing fees—making it a scalable choice for modern pelvic therapy clinics.